Suntrust Banks Inc. Boosts Position in Fresenius Medical Care AG & Co. (FMS)

Suntrust Banks Inc. lifted its holdings in Fresenius Medical Care AG & Co. (NYSE:FMS) by 9.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 33,101 shares of the company’s stock after purchasing an additional 2,993 shares during the quarter. Suntrust Banks Inc.’s holdings in Fresenius Medical Care AG & Co. were worth $1,073,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in FMS. We Are One Seven LLC acquired a new position in shares of Fresenius Medical Care AG & Co. in the fourth quarter valued at about $165,000. LPL Financial LLC grew its stake in shares of Fresenius Medical Care AG & Co. by 38.3% in the third quarter. LPL Financial LLC now owns 6,278 shares of the company’s stock valued at $323,000 after acquiring an additional 1,739 shares in the last quarter. Two Sigma Investments LP acquired a new position in shares of Fresenius Medical Care AG & Co. in the fourth quarter valued at about $7,553,000. Comerica Bank grew its stake in Fresenius Medical Care AG & Co. by 4.2% during the third quarter. Comerica Bank now owns 47,787 shares of the company’s stock worth $1,945,000 after buying an additional 1,912 shares in the last quarter. Finally, Wells Fargo & Company MN grew its stake in Fresenius Medical Care AG & Co. by 221.9% during the third quarter. Wells Fargo & Company MN now owns 272,686 shares of the company’s stock worth $14,022,000 after buying an additional 187,977 shares in the last quarter. 1.88% of the stock is currently owned by institutional investors and hedge funds.

A number of brokerages have issued reports on FMS. SunTrust Banks increased their price objective on shares of Fresenius Medical Care AG & Co. to $48.00 and gave the stock a “positive” rating in a research note on Thursday, February 21st. Royal Bank of Canada reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a research note on Monday, March 18th. Zacks Investment Research upgraded shares of Fresenius Medical Care AG & Co. from a “sell” rating to a “hold” rating in a research note on Tuesday, February 19th. Finally, DZ Bank reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a research note on Tuesday, March 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $65.00.

Shares of FMS traded down $0.70 during mid-day trading on Friday, reaching $39.37. The company had a trading volume of 338,955 shares, compared to its average volume of 251,853. Fresenius Medical Care AG & Co. has a 1-year low of $30.99 and a 1-year high of $53.40. The company has a current ratio of 1.25, a quick ratio of 1.02 and a debt-to-equity ratio of 0.39. The company has a market cap of $24.16 billion, a P/E ratio of 17.34, a PEG ratio of 2.58 and a beta of 1.40.

Fresenius Medical Care AG & Co. (NYSE:FMS) last posted its quarterly earnings results on Wednesday, February 20th. The company reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.64 by $0.02. Fresenius Medical Care AG & Co. had a net margin of 12.00% and a return on equity of 10.14%. The company had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $5.01 billion. On average, equities analysts forecast that Fresenius Medical Care AG & Co. will post 2.46 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Suntrust Banks Inc. Boosts Position in Fresenius Medical Care AG & Co. (FMS)” was first reported by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/04/21/suntrust-banks-inc-buys-2993-shares-of-fresenius-medical-care-ag-co-fms.html.

Fresenius Medical Care AG & Co. Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More: What is the quiet period?

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.